Testing effectiveness (Phase 2)Looking for participantsNCT02727803
What this trial is testing
Personalized NK Cell Therapy in CBT
Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Lymphoblastic Leukemia+23 more
M.D. Anderson Cancer Center 100